Literature DB >> 15166288

Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Puran S Sijwali1, Kentaro Kato, Karl B Seydel, Jiri Gut, Julie Lehman, Michael Klemba, Daniel E Goldberg, Louis H Miller, Philip J Rosenthal.   

Abstract

Among potential new targets for antimalarial chemotherapy are Plasmodium falciparum cysteine proteases, known as falcipains. Falcipain-2 and falcipain-3 are food vacuole hemoglobinases that may have additional functions. The function of falcipain-1 remains uncertain. To better characterize the role of falcipain-1 in erythrocytic parasites, we disrupted the falcipain-1 gene and characterized recombinant parasites. Disruption of the falcipain-1 gene was confirmed with Southern blots, and loss of expression of falcipain-1 was confirmed with immunoblots and by loss of labeling with a specific protease inhibitor. Compared with wild-type parasites, falcipain-1 knockout parasites developed normally, with the same morphology, multiplication rate, and invasion efficiency, and without significant differences in sensitivity to cysteine protease inhibitors. In wild-type and knockout parasites, cysteine protease inhibitors blocked hemoglobin hydrolysis in trophozoites, with a subsequent block in rupture of erythrocytes by mature schizonts, but they did not inhibit erythrocyte invasion by merozoites. Our results indicate that although falcipain-1 is expressed by erythrocytic parasites, it is not essential for normal development during this stage or for erythrocyte invasion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166288      PMCID: PMC423262          DOI: 10.1073/pnas.0402738101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis.

Authors:  S R Brooks; K C Williamson
Journal:  Mol Biochem Parasitol       Date:  2000-02-25       Impact factor: 1.759

2.  Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.

Authors:  M Dua; P Raphael; P S Sijwali; P J Rosenthal; M Hanspal
Journal:  Mol Biochem Parasitol       Date:  2001-08       Impact factor: 1.759

3.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

4.  Stage-specific antimalarial activity of cysteine protease inhibitors.

Authors:  Bhaskar R Shenai; Andrey V Semenov; Philip J Rosenthal
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

5.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

Authors:  P S Sijwali; B R Shenai; J Gut; A Singh; P J Rosenthal
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  Optimisation of flow cytometric measurement of parasitaemia in plasmodium-infected mice.

Authors:  D Barkan; H Ginsburg; J Golenser
Journal:  Int J Parasitol       Date:  2000-04-24       Impact factor: 3.981

Review 7.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden.

Authors:  J G Breman
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

Review 8.  Cysteine proteases of malaria parasites: targets for chemotherapy.

Authors:  Philip J Rosenthal; Puran S Sijwali; Ajay Singh; Bhaskar R Shenai
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

9.  Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis.

Authors:  B L Salmon; A Oksman; D E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  A proteomic view of the Plasmodium falciparum life cycle.

Authors:  Laurence Florens; Michael P Washburn; J Dale Raine; Robert M Anthony; Munira Grainger; J David Haynes; J Kathleen Moch; Nemone Muster; John B Sacci; David L Tabb; Adam A Witney; Dirk Wolters; Yimin Wu; Malcolm J Gardner; Anthony A Holder; Robert E Sinden; John R Yates; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

View more
  30 in total

1.  The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

Authors:  Kailash C Pandey; Stephanie X Wang; Puran S Sijwali; Anthony L Lau; James H McKerrow; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

2.  Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.

Authors:  Manoj K Ramjee; Nicholas S Flinn; Tracy P Pemberton; Martin Quibell; Yikang Wang; John P Watts
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

3.  Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.

Authors:  Amit Kumar; Krishan Kumar; Reshma Korde; Sunil Kumar Puri; Pawan Malhotra; Virander Singh Chauhan
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

4.  Non-canonical maturation of two papain-family proteases in Toxoplasma gondii.

Authors:  Zhicheng Dou; Isabelle Coppens; Vern B Carruthers
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

5.  Drug delivery to the malaria parasite using an arterolane-like scaffold.

Authors:  Shaun D Fontaine; Benjamin Spangler; Jiri Gut; Erica M W Lauterwasser; Philip J Rosenthal; Adam R Renslo
Journal:  ChemMedChem       Date:  2014-10-14       Impact factor: 3.466

6.  Cysteine protease falcipain 1 in Plasmodium falciparum is biochemically distinct from its isozymes.

Authors:  S L Goh; L L Goh; T S Sim
Journal:  Parasitol Res       Date:  2005-07-23       Impact factor: 2.289

7.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Authors:  Frédéric Ariey; Benoit Witkowski; Chanaki Amaratunga; Johann Beghain; Anne-Claire Langlois; Nimol Khim; Saorin Kim; Valentine Duru; Christiane Bouchier; Laurence Ma; Pharath Lim; Rithea Leang; Socheat Duong; Sokunthea Sreng; Seila Suon; Char Meng Chuor; Denis Mey Bout; Sandie Ménard; William O Rogers; Blaise Genton; Thierry Fandeur; Olivo Miotto; Pascal Ringwald; Jacques Le Bras; Antoine Berry; Jean-Christophe Barale; Rick M Fairhurst; Françoise Benoit-Vical; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

8.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.

Authors:  Ying Pei; Jessica L Miller; Scott E Lindner; Ashley M Vaughan; Motomi Torii; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

9.  Trioxolane-Mediated Delivery of Mefloquine Limits Brain Exposure in a Mouse Model of Malaria.

Authors:  Erica M W Lauterwasser; Shaun D Fontaine; Hao Li; Jiri Gut; Kasiram Katneni; Susan A Charman; Philip J Rosenthal; Matthew Bogyo; Adam R Renslo
Journal:  ACS Med Chem Lett       Date:  2015-10-02       Impact factor: 4.345

10.  Plastic parasites: sophisticated strategies for survival and reproduction?

Authors:  Sarah E Reece; Ricardo S Ramiro; Daniel H Nussey
Journal:  Evol Appl       Date:  2009-01-07       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.